DARE - Dare Bioscience, Inc.
1.53
-0.040 -2.614%
Share volume: 57,324
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.57
-0.04
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-14-2024 | 05-13-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 13.013 M | 23.606 M | 18.059 M | 18.619 M | 12.980 M | 30.749 M | |
| Current Assets | 9.983 M | 20.829 M | 14.946 M | 11.823 M | 6.602 M | 25.004 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 152.204 K | 0.000 | 0.000 | 0.000 | 0.000 | 53.159 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.631 M | 16.415 M | 11.233 M | 10.330 M | 5.035 M | 23.075 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 52.493 K | 322.283 K | 706.256 K | 1.485 M | 1.652 M | 1.657 M | |
| Other Assets | 2.978 M | 2.455 M | 2.406 M | 5.311 M | 4.725 M | 4.087 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 13.013 M | 23.606 M | 18.059 M | 18.619 M | 12.980 M | 30.749 M | |
| Total liabilities | 24.012 M | 20.935 M | 19.543 M | 28.183 M | 25.713 M | 27.891 M | |
| Total current liabilities | 17.725 M | 14.590 M | 13.156 M | 21.188 M | 19.221 M | 21.216 M | |
| Accounts Payable | 4.041 M | 1.910 M | 1.049 M | 1.883 M | 1.763 M | 1.845 M | |
| Other liabilities | 5.287 M | 5.345 M | 5.388 M | 5.995 M | 5.492 M | 5.674 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.287 M | 5.345 M | 5.388 M | 5.995 M | 5.492 M | 5.674 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -10.999 M | 2.672 M | -1.484 M | -9.564 M | -12.733 M | 2.858 M | |
| Common stock | 167.392 M | 168.138 M | 168.661 M | 170.520 M | 171.354 M | 190.501 M | |
| Retained earnings | -177.991 M | -165.081 M | -169.783 M | -179.668 M | -183.684 M | -187.247 M |